Semi-Annual Statement Of Income And Retained Earnings

TAIKO PHARMACEUTICAL CO., LTD. - Filing #7270730

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-467,000,000 JPY
-12,000,000 JPY
1,947,000,000 JPY
501,000,000 JPY
629,000,000 JPY
-837,000,000 JPY
1,467,000,000 JPY
-1,005,000,000 JPY
-1,192,000,000 JPY
1,212,000,000 JPY
-996,000,000 JPY
-1,039,000,000 JPY
-28,000,000 JPY
-8,000,000 JPY
Non-operating income
Non-operating income
475,000,000 JPY
86,000,000 JPY
82,000,000 JPY
66,000,000 JPY
Non-operating expenses
Non-operating expenses
30,000,000 JPY
28,000,000 JPY
325,000,000 JPY
358,000,000 JPY
Ordinary profit (loss)
947,000,000 JPY
688,000,000 JPY
-1,248,000,000 JPY
-1,331,000,000 JPY
Extraordinary income
Extraordinary income
210,000,000 JPY
210,000,000 JPY
298,000,000 JPY
298,000,000 JPY
Extraordinary losses
Extraordinary losses
328,000,000 JPY
333,000,000 JPY
2,613,000,000 JPY
2,657,000,000 JPY
Profit (loss) before income taxes
829,000,000 JPY
565,000,000 JPY
-3,563,000,000 JPY
-3,689,000,000 JPY
Income taxes - current
6,000,000 JPY
24,000,000 JPY
23,000,000 JPY
8,000,000 JPY
Income taxes - deferred
-348,000,000 JPY
-357,000,000 JPY
24,000,000 JPY
25,000,000 JPY
Profit (loss)
1,171,000,000 JPY
1,171,000,000 JPY
1,171,000,000 JPY
898,000,000 JPY
1,171,000,000 JPY
-3,611,000,000 JPY
-3,724,000,000 JPY
-3,724,000,000 JPY
-3,724,000,000 JPY
-3,724,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.